PDLIM7 and Hodgkins lymphoma: Interestingly, in line with our findings, despite the fact that LMP-1 of EBV is known for its transforming ability and promotes cellular proliferation in various studies (Baichwal and Sugden, 1988; Kaye et al, 1993), tumours with LMP-1 expression tend to have better prognosis in EBV-associated malignancies such as Hodgkin's disease (Montalban et al, 2000; Glavina-Durdov et al, 2001) and NPC (Hu et al, 1995).